Martin Missbach

Novartis (Switzerland)

Papers

1

Total Citations

59

H-Index

1

About

Martin Missbach is a biochemist and drug discovery researcher whose work has centered on the development of innovative assay technologies for studying protein kinases, particularly tyrosine kinases. His most cited contribution, "A Solid-Phase Assay for the Determination of Protein Tyrosine Kinase Activity of c-src Using Scintillating Microtitration Plates" (1996, 59 citations), introduced a high-throughput, solid-phase method that significantly streamlined the measurement of c-src activity. This assay, which utilized scintillating microtitration plates, eliminated the need for time-consuming separation steps, enabling more efficient screening of kinase inhibitors. Missbach’s work has had a lasting impact on the field of kinase research, providing a foundational tool for drug discovery efforts targeting cancer and other diseases. His contributions exemplify the critical intersection of biochemistry and assay development, and his method remains a reference point for researchers seeking to quantify kinase activity with precision and scalability.

Research Focus

Key Achievements

1
H-Index
1
Papers
59
Total Citations
59
Avg Citations/Paper
🏆 Most Cited Paper
A Solid-Phase Assay for the Determination of Protein Tyrosine Kinase Activity of c-src Using Scintillating Microtitration Plates
59 citations · 1996
📈 Most Prolific Year: 1996 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Novartis (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago